The ototronix MAXUM middle ear implant for severe high-frequency sensorineural hearing loss: Preliminary results

Jacob B. Hunter, Matthew L. Carlson, Michael E. Glasscock

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objectives/Hypothesis: To report the preliminary results of the Ototronix MAXUM middle ear implant for treatment of severe high-frequency sensorineural hearing loss. Study Design: Case series with chart review. Methods: Six consecutive ears with severe high-frequency sensorineural hearing loss (≥75 dB HL at 2, 3, and 4 kHz) and poor aided word recognition performance (≤60% single words) underwent implantation of the MAXUM system at a single, private otologic referral center. Primary outcome measures included frequency-specific functional gain and word recognition score improvement compared to optimally fitted hearing aids. Results: Six ears, in four adult patients (two female; median age 67.5 years) were included. The median unaided preoperative high-frequency pure-tone average (HFPTA) (2, 3, and 4 kHz) was 80.0 dB (range, 75.0–85.0 dB), and the median best-aided word recognition score was 48.0% (range, 24%–60%). The median HFPTA functional gain with the MAXUM system was 47.2 dB, a 25.0 dB improvement (range, 16.7–33.3 dB) (P =.03) over optimally fit hearing aids, and the median word recognition score with MAXUM was 81.5%, a 42.0% improvement (range, 20%–48%) (P =.03) with the MAXUM middle ear implant over optimally fitted hearing aids. Conclusions: These preliminary data demonstrate that the MAXUM middle ear implant provides superior functional gain and word recognition scores in quiet for patients with severe high-frequency sensorineural hearing loss compared to optimally fitted hearing aids. Future studies with greater patient numbers and patient reported outcome measures are needed to confirm these promising but preliminary results. Level of Evidence: 4 Laryngoscope, 126:2124–2127, 2016.

Original languageEnglish (US)
Pages (from-to)2124-2127
Number of pages4
JournalLaryngoscope
Volume126
Issue number9
DOIs
StatePublished - Sep 1 2016

Fingerprint

Ossicular Prosthesis
High-Frequency Hearing Loss
Hearing Aids
Sensorineural Hearing Loss
Ear
Laryngoscopes
Referral and Consultation
Outcome Assessment (Health Care)

Keywords

  • MAXUM
  • Middle ear implant
  • sensorineural hearing loss

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

The ototronix MAXUM middle ear implant for severe high-frequency sensorineural hearing loss : Preliminary results. / Hunter, Jacob B.; Carlson, Matthew L.; Glasscock, Michael E.

In: Laryngoscope, Vol. 126, No. 9, 01.09.2016, p. 2124-2127.

Research output: Contribution to journalArticle

Hunter, Jacob B. ; Carlson, Matthew L. ; Glasscock, Michael E. / The ototronix MAXUM middle ear implant for severe high-frequency sensorineural hearing loss : Preliminary results. In: Laryngoscope. 2016 ; Vol. 126, No. 9. pp. 2124-2127.
@article{c0258064f1354aae8e99b53e0a0ca43b,
title = "The ototronix MAXUM middle ear implant for severe high-frequency sensorineural hearing loss: Preliminary results",
abstract = "Objectives/Hypothesis: To report the preliminary results of the Ototronix MAXUM middle ear implant for treatment of severe high-frequency sensorineural hearing loss. Study Design: Case series with chart review. Methods: Six consecutive ears with severe high-frequency sensorineural hearing loss (≥75 dB HL at 2, 3, and 4 kHz) and poor aided word recognition performance (≤60{\%} single words) underwent implantation of the MAXUM system at a single, private otologic referral center. Primary outcome measures included frequency-specific functional gain and word recognition score improvement compared to optimally fitted hearing aids. Results: Six ears, in four adult patients (two female; median age 67.5 years) were included. The median unaided preoperative high-frequency pure-tone average (HFPTA) (2, 3, and 4 kHz) was 80.0 dB (range, 75.0–85.0 dB), and the median best-aided word recognition score was 48.0{\%} (range, 24{\%}–60{\%}). The median HFPTA functional gain with the MAXUM system was 47.2 dB, a 25.0 dB improvement (range, 16.7–33.3 dB) (P =.03) over optimally fit hearing aids, and the median word recognition score with MAXUM was 81.5{\%}, a 42.0{\%} improvement (range, 20{\%}–48{\%}) (P =.03) with the MAXUM middle ear implant over optimally fitted hearing aids. Conclusions: These preliminary data demonstrate that the MAXUM middle ear implant provides superior functional gain and word recognition scores in quiet for patients with severe high-frequency sensorineural hearing loss compared to optimally fitted hearing aids. Future studies with greater patient numbers and patient reported outcome measures are needed to confirm these promising but preliminary results. Level of Evidence: 4 Laryngoscope, 126:2124–2127, 2016.",
keywords = "MAXUM, Middle ear implant, sensorineural hearing loss",
author = "Hunter, {Jacob B.} and Carlson, {Matthew L.} and Glasscock, {Michael E.}",
year = "2016",
month = "9",
day = "1",
doi = "10.1002/lary.25872",
language = "English (US)",
volume = "126",
pages = "2124--2127",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - The ototronix MAXUM middle ear implant for severe high-frequency sensorineural hearing loss

T2 - Preliminary results

AU - Hunter, Jacob B.

AU - Carlson, Matthew L.

AU - Glasscock, Michael E.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Objectives/Hypothesis: To report the preliminary results of the Ototronix MAXUM middle ear implant for treatment of severe high-frequency sensorineural hearing loss. Study Design: Case series with chart review. Methods: Six consecutive ears with severe high-frequency sensorineural hearing loss (≥75 dB HL at 2, 3, and 4 kHz) and poor aided word recognition performance (≤60% single words) underwent implantation of the MAXUM system at a single, private otologic referral center. Primary outcome measures included frequency-specific functional gain and word recognition score improvement compared to optimally fitted hearing aids. Results: Six ears, in four adult patients (two female; median age 67.5 years) were included. The median unaided preoperative high-frequency pure-tone average (HFPTA) (2, 3, and 4 kHz) was 80.0 dB (range, 75.0–85.0 dB), and the median best-aided word recognition score was 48.0% (range, 24%–60%). The median HFPTA functional gain with the MAXUM system was 47.2 dB, a 25.0 dB improvement (range, 16.7–33.3 dB) (P =.03) over optimally fit hearing aids, and the median word recognition score with MAXUM was 81.5%, a 42.0% improvement (range, 20%–48%) (P =.03) with the MAXUM middle ear implant over optimally fitted hearing aids. Conclusions: These preliminary data demonstrate that the MAXUM middle ear implant provides superior functional gain and word recognition scores in quiet for patients with severe high-frequency sensorineural hearing loss compared to optimally fitted hearing aids. Future studies with greater patient numbers and patient reported outcome measures are needed to confirm these promising but preliminary results. Level of Evidence: 4 Laryngoscope, 126:2124–2127, 2016.

AB - Objectives/Hypothesis: To report the preliminary results of the Ototronix MAXUM middle ear implant for treatment of severe high-frequency sensorineural hearing loss. Study Design: Case series with chart review. Methods: Six consecutive ears with severe high-frequency sensorineural hearing loss (≥75 dB HL at 2, 3, and 4 kHz) and poor aided word recognition performance (≤60% single words) underwent implantation of the MAXUM system at a single, private otologic referral center. Primary outcome measures included frequency-specific functional gain and word recognition score improvement compared to optimally fitted hearing aids. Results: Six ears, in four adult patients (two female; median age 67.5 years) were included. The median unaided preoperative high-frequency pure-tone average (HFPTA) (2, 3, and 4 kHz) was 80.0 dB (range, 75.0–85.0 dB), and the median best-aided word recognition score was 48.0% (range, 24%–60%). The median HFPTA functional gain with the MAXUM system was 47.2 dB, a 25.0 dB improvement (range, 16.7–33.3 dB) (P =.03) over optimally fit hearing aids, and the median word recognition score with MAXUM was 81.5%, a 42.0% improvement (range, 20%–48%) (P =.03) with the MAXUM middle ear implant over optimally fitted hearing aids. Conclusions: These preliminary data demonstrate that the MAXUM middle ear implant provides superior functional gain and word recognition scores in quiet for patients with severe high-frequency sensorineural hearing loss compared to optimally fitted hearing aids. Future studies with greater patient numbers and patient reported outcome measures are needed to confirm these promising but preliminary results. Level of Evidence: 4 Laryngoscope, 126:2124–2127, 2016.

KW - MAXUM

KW - Middle ear implant

KW - sensorineural hearing loss

UR - http://www.scopus.com/inward/record.url?scp=84983376350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983376350&partnerID=8YFLogxK

U2 - 10.1002/lary.25872

DO - 10.1002/lary.25872

M3 - Article

C2 - 26972428

AN - SCOPUS:84983376350

VL - 126

SP - 2124

EP - 2127

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 9

ER -